Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study
Summary: Background: A previous validated study has identified the diagnostic value of circulating exosomal lncRNA-GC1 for detecting and monitoring gastric cancer. We aimed to further determine the predictive role of circulating exosomal lncRNA-GC1 for prognosis and chemotherapy response. Methods:...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-04-01
|
| Series: | EBioMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396422001554 |
| _version_ | 1828423119450144768 |
|---|---|
| author | Qiying Song, MD Xiaohui Lv, MD Yi Ru, PhD Jian Dong, PhD Rongyan Chang, PhD Di Wu, MD Lubin Chen, MD Xinxin Wang, PhD Xin Guo, PhD |
| author_facet | Qiying Song, MD Xiaohui Lv, MD Yi Ru, PhD Jian Dong, PhD Rongyan Chang, PhD Di Wu, MD Lubin Chen, MD Xinxin Wang, PhD Xin Guo, PhD |
| author_sort | Qiying Song, MD |
| collection | DOAJ |
| description | Summary: Background: A previous validated study has identified the diagnostic value of circulating exosomal lncRNA-GC1 for detecting and monitoring gastric cancer. We aimed to further determine the predictive role of circulating exosomal lncRNA-GC1 for prognosis and chemotherapy response. Methods: We retrospectively conducted a multi-phase analysis with four independent cohorts of 981 patients. A training cohort was used to generate the predictive model. One internal and two external cohorts were recruited as validation cohorts. Patients with stage II or III gastric cancer in the combined cohort were used to evaluate the predictive value of circulating exosomal lncRNA-GC1 for chemotherapy response. Findings: In the training cohort, circulating exosomal lncRNA-GC1 was identified as an independent prognostic predictor for disease-free and overall survival. A prognostic risk stratification model based on circulating exosomal lncRNA-GC1 and AJCC stage revealed better predictive accuracy for disease-free and overall survival than the traditional AJCC stage system alone (C-index: DFS 0.701 vs 0.614; OS 0.720 vs 0.611, both P<0.05). And it has been further verified in the validation cohorts. In interaction analysis, for stage II and III GC, patients with low-level of circulating exosomal lncRNA-GC1 derived more survival benefit from adjuvant chemotherapy (P < 0.05); while those with high-level did not. Interpretation: Measurement of circulating exosomal lncRNA-GC1 provides clinically important prognostic information and could complement the AJCC stage to optimize decision-making for selecting patients who could benefit more from fluorouracil-based chemotherapy after surgery. Funding: The funders are listed in the Acknowledgement. |
| first_indexed | 2024-12-10T15:57:46Z |
| format | Article |
| id | doaj.art-0d64107471f8458e8e7ce2c7f0e3f4e5 |
| institution | Directory Open Access Journal |
| issn | 2352-3964 |
| language | English |
| last_indexed | 2024-12-10T15:57:46Z |
| publishDate | 2022-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EBioMedicine |
| spelling | doaj.art-0d64107471f8458e8e7ce2c7f0e3f4e52022-12-22T01:42:34ZengElsevierEBioMedicine2352-39642022-04-0178103971Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase studyQiying Song, MD0Xiaohui Lv, MD1Yi Ru, PhD2Jian Dong, PhD3Rongyan Chang, PhD4Di Wu, MD5Lubin Chen, MD6Xinxin Wang, PhD7Xin Guo, PhD8Department of General Surgery, Chinese PLA General Hospital, Beijing, 100853, China.Department of Gynecology and Obstetrics, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, ChinaDepartment of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, 710032, ChinaDepartment of Gynecology and Obstetrics, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, ChinaDepartment of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of Endoscopic Surgery, Air Force 986th Hospital, Fourth Military Medical University, Xi'an, 710032, ChinaDepartment of General Surgery, Chinese PLA General Hospital, Beijing, 100853, China.Department of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of Endoscopic Surgery, Air Force 986th Hospital, Fourth Military Medical University, Xi'an, 710032, ChinaDepartment of General Surgery, Chinese PLA General Hospital, Beijing, 100853, China.; Correspondence to: Prof. Xin Guo(primary correspondinng author), Department of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Changle East Rd, Xi’an, 710032, China；Prof. Xinxin Wang(co-correspondinng author), Department of General Surgery, Chinese PLA General Hospital, Fuxing Rd, Beijing, 100853, China.Department of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of Endoscopic Surgery, Air Force 986th Hospital, Fourth Military Medical University, Xi'an, 710032, China; Department of General Surgery, Chinese PLA General Hospital, Beijing, 100853, China.; Correspondence to: Prof. Xin Guo(primary correspondinng author), Department of Digestive Surgery, Xijing Hospital, Fourth Military Medical University, Changle East Rd, Xi’an, 710032, China；Prof. Xinxin Wang(co-correspondinng author), Department of General Surgery, Chinese PLA General Hospital, Fuxing Rd, Beijing, 100853, China.Summary: Background: A previous validated study has identified the diagnostic value of circulating exosomal lncRNA-GC1 for detecting and monitoring gastric cancer. We aimed to further determine the predictive role of circulating exosomal lncRNA-GC1 for prognosis and chemotherapy response. Methods: We retrospectively conducted a multi-phase analysis with four independent cohorts of 981 patients. A training cohort was used to generate the predictive model. One internal and two external cohorts were recruited as validation cohorts. Patients with stage II or III gastric cancer in the combined cohort were used to evaluate the predictive value of circulating exosomal lncRNA-GC1 for chemotherapy response. Findings: In the training cohort, circulating exosomal lncRNA-GC1 was identified as an independent prognostic predictor for disease-free and overall survival. A prognostic risk stratification model based on circulating exosomal lncRNA-GC1 and AJCC stage revealed better predictive accuracy for disease-free and overall survival than the traditional AJCC stage system alone (C-index: DFS 0.701 vs 0.614; OS 0.720 vs 0.611, both P<0.05). And it has been further verified in the validation cohorts. In interaction analysis, for stage II and III GC, patients with low-level of circulating exosomal lncRNA-GC1 derived more survival benefit from adjuvant chemotherapy (P < 0.05); while those with high-level did not. Interpretation: Measurement of circulating exosomal lncRNA-GC1 provides clinically important prognostic information and could complement the AJCC stage to optimize decision-making for selecting patients who could benefit more from fluorouracil-based chemotherapy after surgery. Funding: The funders are listed in the Acknowledgement.http://www.sciencedirect.com/science/article/pii/S2352396422001554ExosomeLncRNA-GC1Adjuvant chemotherapyPrognosisGastric cancer |
| spellingShingle | Qiying Song, MD Xiaohui Lv, MD Yi Ru, PhD Jian Dong, PhD Rongyan Chang, PhD Di Wu, MD Lubin Chen, MD Xinxin Wang, PhD Xin Guo, PhD Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study EBioMedicine Exosome LncRNA-GC1 Adjuvant chemotherapy Prognosis Gastric cancer |
| title | Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study |
| title_full | Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study |
| title_fullStr | Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study |
| title_full_unstemmed | Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study |
| title_short | Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study |
| title_sort | circulating exosomal gastric cancer associated long noncoding rna1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer a multi cohort multi phase study |
| topic | Exosome LncRNA-GC1 Adjuvant chemotherapy Prognosis Gastric cancer |
| url | http://www.sciencedirect.com/science/article/pii/S2352396422001554 |
| work_keys_str_mv | AT qiyingsongmd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT xiaohuilvmd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT yiruphd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT jiandongphd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT rongyanchangphd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT diwumd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT lubinchenmd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT xinxinwangphd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy AT xinguophd circulatingexosomalgastriccancerassociatedlongnoncodingrna1asanoninvasivebiomarkerforpredictingchemotherapyresponseandprognosisofadvancedgastriccanceramulticohortmultiphasestudy |